Literature DB >> 6965549

Reduction of postoperative pain and narcotic use by transcutaneous electrical nerve stimulation.

R A Solomon, M C Viernstein, D M Long.   

Abstract

Transcutaneous electrical nerve stimulation (TENS) was evaluated as a postoperative analgesic. Patients undergoing lumbar spine operations, hip surgery, and gynecological laparotomies were studied. Sterile electrodes, placed near the incision immediately after operation, were connected to a continuously operating stimulator for 48 hours after operation. Results from 46 experimental patients demonstrated that TENS could reduce the demand for postoperative narcotics in a group of patients who had not used narcotic analgesics before operation. No significant benefit was observed for patients who had used narcotics prior to operation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6965549

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  4 in total

1.  Transcutaneous electrical nerve stimulation and postoperative use of narcotic analgesics.

Authors:  G Strayhorn
Journal:  J Natl Med Assoc       Date:  1983-08       Impact factor: 1.798

2.  Analgesic Tolerance Development during Repetitive Electric Stimulations Is Associated with Changes in the Expression of Activated Microglia in Rats with Osteoarthritis.

Authors:  Suk-Chan Hahm; Jin Seung Lee; Young Wook Yoon; Junesun Kim
Journal:  Biomedicines       Date:  2020-12-07

3.  Effects of high-frequency, high-intensity transcutaneous electrical nerve stimulation versus intravenous opioids for pain relief after gynecologic laparoscopic surgery: a randomized controlled study.

Authors:  Birgitta Platon; Clas Mannheimer; Paulin Andréll
Journal:  Korean J Anesthesiol       Date:  2018-04-02

4.  The impact of low-dose glucocorticoids on disease activity, bone mineral density, fragility fractures, and 10-year probability of fractures in patients with rheumatoid arthritis.

Authors:  Tien-Tsai Cheng; Han-Ming Lai; Shan-Fu Yu; Wen-Chan Chiu; Chung-Yuan Hsu; Jia-Feng Chen; Ying-Chou Chen
Journal:  J Investig Med       Date:  2018-06-10       Impact factor: 2.895

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.